How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/chronic-myelomonocytic-leukemia.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Chronic myelomonocytic leukemia — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Chronic myelomonocytic leukemia (disease) competitive landscape: 3 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

3 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Chronic myelomonocytic leukemia, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Inqovi	Inqovi	Otsuka	Nucleoside Metabolic Inhibitor [EPC]	Cytidine deaminase	2020-01-01
Vidaza	azacitidine	Bristol-Myers Squibb	Nucleoside Metabolic Inhibitor [EPC]	DNA (cytosine-5)-methyltransferase 1	2004-01-01
azacytidine	azacytidine	Assistance Publique Hopitaux De Marseille		DNA (cytosine-5)-methyltransferase 1, DNA (cytosine-5)-methyltransferase 3A

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Assistance Publique Hopitaux De Marseille · 1 drug in Chronic myelomonocytic leukemia
Bristol-Myers Squibb · 1 drug in Chronic myelomonocytic leukemia
Otsuka · 1 drug in Chronic myelomonocytic leukemia

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Chronic myelomonocytic leukemia:

Cite this brief

Drug Landscape (2026). Chronic myelomonocytic leukemia — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/chronic-myelomonocytic-leukemia. Accessed 2026-06-10.

Chronic myelomonocytic leukemia full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing